STOCK TITAN

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

RxSight, Inc. (NASDAQ: RXST) has announced its participation in the J.P. Morgan Healthcare Conference, scheduled for January 11, 2023, at 11:15 a.m. PT. This event focuses on enhancing vision for cataract surgery patients through innovative technologies. RxSight's Light Adjustable Lens system is the first customizable intraocular lens technology aimed at optimizing post-surgery visual acuity. Interested parties can access the live and archived webcast via this link.

Positive
  • None.
Negative
  • None.

ALISO VIEJO, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference.

RxSight’s management is scheduled to present on Wednesday, January 11, 2023, at 11:15 a.m. Pacific Time / 2:15 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.

About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com

Investor Relations Contact:
ir@rxsight.com


FAQ

When will RxSight participate in the J.P. Morgan Healthcare Conference?

RxSight will present at the J.P. Morgan Healthcare Conference on January 11, 2023, at 11:15 a.m. Pacific Time.

What technology does RxSight offer for cataract surgery patients?

RxSight offers the Light Adjustable Lens system, the first customizable intraocular lens technology to enhance visual acuity after cataract surgery.

How can I access the RxSight presentation at the J.P. Morgan Healthcare Conference?

The presentation will be available via a live and archived webcast at RxSight's investor relations website.

What is the stock symbol for RxSight?

The stock symbol for RxSight is RXST.

What is the significance of the Light Adjustable Lens system?

The Light Adjustable Lens system allows doctors to customize and optimize vision outcomes for cataract surgery patients, making it a unique offering in the market.

RxSight, Inc.

NASDAQ:RXST

RXST Rankings

RXST Latest News

RXST Stock Data

1.43B
38.26M
5.08%
89.48%
7.52%
Medical Devices
Ophthalmic Goods
Link
United States of America
ALISO VIEJO